Research Topics
| Gillian M KeatingSummaryAffiliation: Adis International Inc Country: USA Publications
| Collaborators
|
Detail Information
Publications
Valsartan: in chronic heart failureKeri Wellington
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Cardiovasc Drugs 2:267-74; discussion 275-6. 2002..The most common adverse events in the valsartan and placebo groups which led to discontinuation of treatment were dizziness, renal impairment (both of which occurred in significantly more valsartan recipients) and hypotension...
Pimecrolimus: a review of its use in atopic dermatitisKeri Wellington
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 5:479-95. 2004..Thus, topical pimecrolimus 1% cream is an effective treatment option for the management of mild-to-moderate atopic dermatitis...
EfalizumabKeri Wellington
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 6:113-8; discussion 119-20. 2005....
Spotlight on cefditoren pivoxil in bacterial infectionsKeri Wellington
Adis International Inc, Yardley, Pennsylvania 19067, USA
Treat Respir Med 4:149-52. 2005....
Ipratropium bromide HFAKeri Wellington
Adis International Inc, Yardley, Pennsylvania 19067, USA
Treat Respir Med 4:215-20; discussion 221-2. 2005..The most common adverse events were related to respiratory system disorders. During the 1-year study, dry mouth was reported by 1.3% and 0.7% of patients in the ipratropium bromide HFA or ipratropium bromide CFC groups...
Crotalidae polyvalent immune Fab: a guide to its use in North American crotaline envenomationGillian M Keating
Adis, Auckland, New Zealand
Clin Drug Investig 32:555-60. 2012..g. coagulopathy). Intravenous crotalidae polyvalent immune Fab is generally well tolerated, with acute hypersensitivity reactions being the most commonly occurring adverse event...
Polyphenon E 10% ointment: in immunocompetent adults with external genital and perianal wartsSheridan M Hoy
Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Am J Clin Dermatol 13:275-81. 2012..According to pooled data from the two clinical studies, the majority of adverse events associated with polyphenon E 10% ointment involved application site and local skin reactions at the treatment site...
Intravenous ibuprofen: in adults for pain and feverLesley J Scott
Adis, Auckland, New Zealand
Drugs 72:1099-109. 2012..Intravenous ibuprofen was generally well tolerated by hospitalized adult patients participating in these clinical trials. The most common adverse event leading to discontinuation of ibuprofen treatment was pruritus (<1% of patients)...
Azacitidine: a review of its use in the management of myelodysplastic syndromes/acute myeloid leukaemiaGillian M Keating
Adis, Auckland, New Zealand
Drugs 72:1111-36. 2012..g. nausea, vomiting and diarrhoea) and injection-site reactions among the most commonly occurring non-haematological adverse events. In conclusion, azacitidine is an important agent for use in the treatment of patients with MDS/AML...
Ulipristal acetate: in uterine fibroidsJamie D Croxtall
Adis, Auckland, New Zealand
Drugs 72:1075-85. 2012..Ulipristal acetate was generally well tolerated in women with uterine fibroids. The incidence of hot flush occurred with a significantly lower frequency for recipients of ulipristal acetate than for recipients of leuprolide acetate...
Prasugrel: a guide to its use in patients with acute coronary syndromes undergoing percutaneous coronary intervention in the USKatherine A Lyseng-Williamson
Adis, Auckland, New Zealand
Am J Cardiovasc Drugs 12:207-16. 2012..Limited pharmacoeconomic analyses suggest that prasugrel-based therapy is an economically attractive treatment strategy relative to clopidogrel-based therapy from a US healthcare payer perspective...
Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgeryCeleste B Burness
Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Drugs 72:963-86. 2012..In the meantime, dabigatran etexilate offers a convenient, effective and generally well tolerated treatment option for the prophylaxis of VTE in patients undergoing TKR and THR surgery...
Bevacizumab combination therapy: for the first-line treatment of advanced epithelial ovarian, fallopian tube or primary peritoneal cancerSohita Dhillon
Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Drugs 72:917-30. 2012..Bevacizumab combination therapy had generally acceptable tolerability in these studies, with the nature of adverse events generally similar to that observed in previous clinical trials in patients with other solid tumours...
Dihydroartemisinin/Piperaquine: a review of its use in the treatment of uncomplicated Plasmodium falciparum malariaGillian M Keating
Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Drugs 72:937-61. 2012..In conclusion, dihydroartemisinin/piperaquine is a valuable option for use in the first-line treatment of uncomplicated P. falciparum malaria...
Quetiapine: a review of its use in the management of bipolar depressionMark Sanford
Adis, Auckland, New Zealand
CNS Drugs 26:435-60. 2012..Further head-to-head trials of quetiapine versus other drug regimens that are effective in bipolar depression would be of considerable interest...
Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgarisCaroline Fenton
Adis International Limited, Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 5:463-78. 2004..The safety of calcipotriol/betamethasone dipropionate in patients treated for up to 1 year was generally good; fewer than 5% of patients experienced adverse events possibly associated with long-term corticosteroid use...
The Novolizer: a multidose dry powder inhalerM Asif A Siddiqui
Adis International Inc, 770 Township Line Road, Suite 300, Yardley, PA 19067, USA
Treat Respir Med 4:63-9. 2005..Overall, the Novolizer was well accepted, with an improved compliance in 80% of patients that was attributable to the control mechanisms of the device...
Spotlight on insulin glargine in type 1 and 2 diabetes mellitusKate McKeage
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Treat Endocrinol 1:55-8. 2002..Therefore, insulin glargine is likely to be a useful addition to the armamentarium of insulin therapy by establishing basal glycemic control with once daily administration and a reduced risk of nocturnal hypoglycemia...
Spotlight on estradiol and norgestimate as hormone replacement therapy in postmenopausal womenMonique P Curran
Adis International Limited, Langhorne, Pennsylvania 19047, USA
Treat Endocrinol 1:127-9. 2002..In the meantime, continuous oral estradiol plus intermittent oral norgestimate can be regarded as an effective new option for HRT in postmenopausal women...
Etanercept: a review of its use in the management of plaque psoriasis and psoriatic arthritisDavid R Goldsmith
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 6:121-36. 2005....
Spotlight on adapalene in acne vulgarisJohn Waugh
Adis International Inc, Yardley, PA 19067, USA
Am J Clin Dermatol 5:369-71. 2004..These attributes can potentially promote patient compliance, an important factor in treatment success. Adapalene is, therefore, assured of a role in the first-line treatment of acne vulgaris...
Poly-L-lactic acidCaroline M Perry
Adis International Inc Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 5:361-6; discussion 367-8. 2004..Poly-L-lactic acid was generally well tolerated. No serious adverse events were reported...
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPDSusan J Keam
Adis International Inc, Yardley, Pennsylvania, USA
Treat Respir Med 3:247-68. 2004..Similar proportions of tiotropium, salmeterol, and placebo recipients required COPD-related hospitalizations. (ABSTRACT TRUNCATED)..
Extended-release metformin hydrochloride. Single-composition osmotic tablet formulationAntona J Wagstaff
Adis International Inc, Yardley, Pennsylvania, USA
Treat Endocrinol 3:327-32. 2004..Like the IR formulation, metformin XT is generally well tolerated; gastro-intestinal adverse events are, however, common...
17 beta-estradiol/levonorgestrel transdermal systemToni M Dando
Adis International Inc, Yardley, Pennsylvania, USA
Treat Endocrinol 3:319-24. 2004..The estradiol/levonorgestrel transdermal system was generally well tolerated. In two trials, application-site reactions were common in all treatment groups (estradiol/levonorgestrel, estradiol, and placebo)...
The paclitaxel (TAXUS)-eluting stent: a review of its use in the management of de novo coronary artery lesionsJohn Waugh
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 4:257-68. 2004..PHARMACOECONOMIC CONSIDERATIONS: Initial deployment costs associated with the PES are likely to be offset by savings in repeat procedures, according to a cost-effectiveness analysis in the UK...
Omalizumab: a review of its use in the management of allergic asthmaLynne M Bang
Adis International Inc, Yardley, Pennsylvania 19607, USA
Treat Respir Med 3:183-99. 2004..Comparisons of omalizumab with other asthma therapies have yet to be conducted; however, clinical efficacy and tolerability data indicate that omalizumab is a valuable option in the treatment of allergic asthma...
Palivizumab: a review of its use as prophylaxis for serious respiratory syncytial virus infectionCaroline Fenton
Adis International Inc, Yardley, Pennsylvania 19067, USA
Paediatr Drugs 6:177-97. 2004..The use of palivizumab in these other high-risk populations is likely to be determined as much by pharmacoeconomic considerations as by efficacy outcomes...
Topical methyl aminolevulinateM Asif A Siddiqui
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Clin Dermatol 5:127-37; discussion 138-40. 2004..The most frequently reported adverse events were local phototoxicity reactions, most of which were of mild to moderate intensity, resolved rapidly and were rarely treatment limiting...
Rosuvastatin: a review of its use in the management of dyslipidemiaLesley J Scott
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 4:117-38. 2004..Thus, rosuvastatin has emerged as a valuable choice for first-line treatment in the management of low- to high-risk patients requiring lipid-lowering drug therapy...
Lucinactant: in neonatal respiratory distress syndromeMarit D Moen
Adis International Inc, Yardley, Pennsylvania 19067, USA
Treat Respir Med 4:139-45; discussion 146-7. 2005..Adverse events were transient and related to the administration procedure. There were no differences in the incidences of complications of prematurity between lucinactant and the other surfactants...
Reteplase: a review of its use in the management of thrombotic occlusive disordersDene Simpson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 6:265-85. 2006....
Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosisVicki Oldfield
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 6:189-208. 2006..Thus, in accordance with current clinical guidelines, bosentan is a convenient, effective, and generally well tolerated agent for use in the first-line treatment of class III PAH or second-line treatment of class IV PAH...
Rotavirus vaccine (RotaTeq)Gillian M Keating
Adis International Inc, Yardley, PA 19067, USA
Paediatr Drugs 8:197-202; discussion 203-4. 2006..Rotavirus vaccine and placebo were associated with serious adverse events in <3% of infants in either group...
T-SPOT.TB: an in vitro diagnostic assay measuring T-cell reaction to Mycobacterium tuberculosis-specific antigensAntona J Wagstaff
Adis International Inc, Yardley, Pennsylvania 19067, USA
Mol Diagn Ther 10:57-63; discussion 64-5. 2006..Unlike the TST, the RD1 ELISPOT assay is not confounded by bacille Calmette-Guérin vaccination...
Spotlight on etanercept in plaque psoriasis and psoriatic arthritisDavid R Goldsmith
Adis International Inc, 770 Township Line Road, Suite 300, Yardley, Pennsylvania 19067, USA
BioDrugs 19:401-3. 2005....
Once-monthly ibandronateToni M Dando
Adis International Inc, Yardley, Pennsylvania, USA
Treat Endocrinol 4:381-7; discussion 389-90. 2005..Significantly more women with osteoporosis preferred once-monthly ibandronate and found it more convenient than once-weekly alendronate, according to data from a 6-month, randomized, open-label, crossover study...
Alendronate/colecalciferolNeil A Reynolds
Adis International Inc, Yardley, Pennsylvania, USA
Treat Endocrinol 4:371-7; discussion 379. 2005..The treatment-related adverse event profile of once-weekly alendronate/colecalciferol 70 mg/2800 IU was similar to that of once-weekly alendronate in the 15-week, double-blind study in patients with osteoporosis...
Darbepoetin alfa: its use in anemia associated with chronic kidney diseaseDean M Robinson
Adis International Inc, Yardley, Pennsylvania 19067, USA
BioDrugs 19:327-43. 2005....
Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolismDean M Robinson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 5:335-46. 2005..It thus provides a valuable alternative to UFH and low-molecular weight heparins in the treatment of acute VTE, particularly in the outpatient setting...
Clofarabine: in pediatric patients with acute lymphoblastic leukemiaMonique P Curran
Adis International Inc, Yardley, Pennsylvania 19067, USA
Paediatr Drugs 7:259-64; discussion 265-6. 2005..Capillary leak syndrome or systemic inflammatory response syndrome was reported in four patients...
Anakinra: a review of its use in the management of rheumatoid arthritisJohn Waugh
Adis International Inc, Yardley, Pennsylvania 19067, USA
BioDrugs 19:189-202. 2005..It is subcutaneously administered and is generally well tolerated. Anakinra offers a useful addition to the range of drugs available for the treatment of RA...
Risedronate once a weekNgaire J White
Adis International Inc, Yardley, Pennsylvania, 19067, USA
Treat Endocrinol 2:415-20; discussion 421. 2003..The tolerability profile (including the incidence of upper gastrointestinal adverse events) of risedronate 35mg once a week in women with postmenopausal osteoporosis, was similar to that of risedronate 5mg once daily...
Spotlight on paricalcitol in secondary hyperparathyroidismDean M Robinson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Treat Endocrinol 4:185-6. 2005..Thus, paricalcitol is a useful option for the management of secondary hyperparathyroidism in adults and children with chronic renal failure...
Ethinylestradiol/drospirenone: a review of its use as an oral contraceptiveSusan J Keam
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Treat Endocrinol 2:49-70. 2003....
Spotlight on rosiglitazone in the management of type 2 diabetes mellitusAntona J Wagstaff
Adis International Inc, Langhorne, Pennsylvania, USA
Treat Endocrinol 1:411-4. 2002..Rosiglitazone significantly improves insulin sensitivity and, as such, is a welcome addition to the treatment options for patients with type 2 diabetes mellitus...
Intravenous conivaptanMarit D Moen
Wolters Kluwer Health Adis, Auckland, New Zealand
Am J Cardiovasc Drugs 8:341-8; discussion 349. 2008..The most common adverse events were injection related (e.g. injection-site phlebitis), hypotension, and pyrexia...
Clopidogrel: potential in the prevention of cardiovascular events in patients with acute coronary syndromesS E Easthope
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Cardiovasc Drugs 1:467-74; discussion 475-6. 2001..However, there was no difference between the two groups in the incidence of bleeding episodes that were considered to be life-threatening...
Micronized fenofibrate in dyslipidemia: a focus on plasma high-density lipoprotein cholesterol (HDL-C) levelsMiriam Sharpe
Adis International Limited, Langhorne, Pennsylvania 19047, USA
Am J Cardiovasc Drugs 2:125-32; discussion 133-4. 2002..In double-blind, placebo-controlled trials in a total of 804 patients, the pooled incidences of individual adverse events were generally similar with fenofibrate and placebo...
Linezolid: in infants and children with severe Gram-positive infectionsKatherine A Lyseng-Williamson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Paediatr Drugs 5:419-29; discussion 430-1. 2003..Linezolid is generally well tolerated. The most common drug-related adverse events in the comparator-controlled trials were diarrhea, nausea, and headache; most events were mild to moderate in severity...
Oxcarbazepine: a review of its use in children with epilepsyLynne Bang
Adis International Inc, Yardley, Pennsylvania 19067, USA
Paediatr Drugs 5:557-73. 2003..Nevertheless, the generally favorable tolerability profile and relatively low potential for drug interactions of oxcarbazepine make it a valuable option in the treatment of childhood epilepsy...
Cilostazol: a review of its use in intermittent claudicationTherese M Chapman
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Cardiovasc Drugs 3:117-38. 2003..Nonetheless, current data support the choice of cilostazol as a promising therapy amongst the limited options available for patients with intermittent claudication...
Spotlight on topical pimecrolimus in atopic dermatitisKeri Wellington
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Clin Dermatol 3:435-8. 2002..Topical pimecrolimus 1.0% provides a promising and well tolerated treatment option in the management of infants, children and adults with mild to moderate atopic dermatitis...
Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infectionNila Bhana
Adis International Inc, 860 Town Center Drive, Langhorne, PA 19047, USA
Paediatr Drugs 4:515-53. 2002....
Cefepime: a review of its use in the management of hospitalized patients with pneumoniaTherese M Chapman
Adis International Inc, Langhorne, Pennsylvania 19407, USA
Am J Respir Med 2:75-107. 2003..With prudent use in order to prevent the emergence of resistant organisms, cefepime will continue to be a suitable option for the empiric treatment of pneumonia...
Spotlight on zanamivir in influenzaSusan M Cheer
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Respir Med 1:147-52. 2002..Zanamivir shows potential for prophylaxis in persons for whom vaccination is contraindicated or ineffective, in elderly or high-risk patients in long-term care facilities and in households...
Spotlight on montelukast in asthma in children 2 to 14 years of ageRichard B R Muijsers
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Respir Med 1:225-8. 2002..In addition, the drug offers significant benefits when added to inhaled corticosteroids (according to secondary endpoints). Montelukast offers an effective, well tolerated and convenient treatment option for children with asthma...
Lamivudine: in children and adolescents with chronic hepatitis B virus infectionSusan J Keam
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Paediatr Drugs 4:687-94; discussion 695-6. 2002..Oral lamivudine is generally well tolerated by children and adolescents with chronic hepatitis B, with a similar tolerability profile to placebo at the recommended once daily dosage of 3 mg/kg up to a maximum of 100 mg/day...
Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary diseaseKatherine A Lyseng-Williamson
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Respir Med 1:273-82; discussion 283-4. 2002..Candidiasis, hoarseness/dysphonia, throat irritation and headache occurred more frequently with salmeterol/fluticasone propionate than with placebo in patients with COPD...
AtomoxetineDene Simpson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Paediatr Drugs 5:407-15; discussion 416-7. 2003..The most common treatment-related adverse event was decreased appetite. Atomoxetine shows no abuse potential and is not a controlled substance in the US...
Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarctionC J Dunn
Adis International Inc, Langhorne, Pennsylvania, USA
Am J Cardiovasc Drugs 1:51-66. 2001....
Clobetasol propionate foam, 0.05%E B Melian
Adis International Inc, Langhorne, Pennsylvania, USA
Am J Clin Dermatol 2:89-92; discussion 93. 2001..Clobetasol foam 7 g/day for 2 weeks induced reversible suppression of the hypothalamic-pituitary-adrenal axis in 3 out of 13 patients (methodology of assessment not provided)...
Lansoprazole: in the management of gastroesophageal reflux disease in childrenLesley J Scott
Adis International Inc, Langhorne, Pennsylvania 10947, USA
Paediatr Drugs 5:57-61; discussion 62. 2003..The drug is generally well tolerated in children with GERD. In the largest study, the most common treatment-related adverse events occurring during therapy were constipation and headache...
Calcipotriol ointment. A review of its use in the management of psoriasisL J Scott
Adis International Inc, Langhorne, Pennsylvania, USA
Am J Clin Dermatol 2:95-120. 2001..Calcipotriol ointment is valuable as a first- or second-line therapy option for the management of mild to moderate psoriasis and in combination with other antipsoriatic agents for more severe psoriasis...
Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularizationTim Ibbotson
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 3:381-6. 2003..Abciximab remains an important therapeutic option for the prevention of complications in patients with ischaemic heart disease...
Formoterol delivered by Turbuhaler: in pediatric asthmaSusan M Cheer
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Paediatr Drugs 5:63-8; discussion 69. 2003..Formoterol delivered by Turbuhaler was well tolerated in pediatric patients, with respiratory infection being the most commonly reported adverse event...
AlefaceptJames Frampton
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Clin Dermatol 4:277-86; discussion 287. 2003..No opportunistic infections have been reported, nor is there evidence of an increased risk of malignancies...
Formoterol: a review of its use in chronic obstructive pulmonary diseaseSusan M Cheer
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Respir Med 1:285-300. 2002..Thus, inhaled formoterol may be considered as a first-line option for the management of bronchoconstriction in patients with COPD who require regular bronchodilator therapy for the management of symptoms...
Losartan: in the reduction of stroke risk in patients with hypertension and left ventricular hypertrophyJohn Waugh
Adis International Inc, Yardley, Pennsylvania 19067, USA
Am J Cardiovasc Drugs 3:371-7; discussion 378-9. 2003..Significantly fewer losartan than atenolol recipients discontinued treatment because of adverse events, drug-related adverse events, or serious, drug-related adverse events...
Flunisolide HFAJohn Waugh
Adis International Inc, Langhorne, Pennsylvannia 19047, USA
Am J Respir Med 1:369-72; discussion 373. 2002..Flunisolide HFA was well tolerated in all trials. A long-term study found no suppression of adrenal function and minimal systemic effects were observed both in adults and children...
MemantineBlair Jarvis
Adis International Limited, Auckland, New Zealand
Drugs Aging 20:465-76; discussion 477-8. 2003..Adverse events (incidence in memantine recipients greater than in placebo recipients) occurring in patients with moderately severe to severe dementia included diarrhoea, insomnia, dizziness, headache and hallucination...
Clindamycin/benzoyl peroxide gel: a review of its use in the management of acneGregory T Warner
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Clin Dermatol 3:349-60. 2002..It is a suitable alternative for patients who are currently using topical antibacterials either alone or in conjunction with other topical anti-acne agents or systemic antibacterials...
Spotlight on ranolazine in chronic stable angina pectorisM Asif A Siddiqui
Wolters Kluwer Health Adis, Auckland, New Zealand
Am J Cardiovasc Drugs 6:357-9. 2006..Nevertheless, ranolazine ER may well prove to be a useful alternative and adjunct to conventional hemodynamic antianginal therapy in the treatment of chronic stable angina...
Tacrolimus ointment: a review of its use in atopic dermatitis and its clinical potential in other inflammatory skin conditionsDene Simpson
Adis International Limited, Auckland, New Zealand
Drugs 65:827-58. 2005....
BosentanAmitabh Prakash
Adis International Inc, Langhorne, Pennsylvania 19047, USA
Am J Cardiovasc Drugs 2:335-43; discussion 343. 2002..Those that occurred less frequently with bosentan 125 mg twice daily than with placebo included dizziness, worsening of symptoms of pulmonary arterial hypertension, cough and dyspnea...
Spotlight on reteplase in thrombotic occlusive disordersDene Simpson
Wolters Kluwer Health Adis, Auckland, New Zealand
BioDrugs 21:65-8. 2007....
Adapalene: a review of its use in the treatment of acne vulgarisJohn Waugh
Adis International Limited, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, Auckland 1311, New Zealand
Drugs 64:1465-78. 2004..These attributes can potentially promote patient compliance, an important factor in treatment success. Adapalene is, therefore, assured of a role in the first-line treatment of acne vulgaris...
Spotlight on pegfilgrastim in chemotherapy-induced neutropeniaJames E Frampton
Adis International Inc, 770 Township Line Road, Suite 300, Yardley, Pennsylvania 19067, USA
BioDrugs 19:405-7. 2005..Pegfilgrastim should, likewise, permit simplification of G-CSF-based stem cell mobilization and transplantation procedures...
Saquinavir: a review of its use in boosted regimens for treating HIV infectionGreg L Plosker
Adis International Limited, Auckland, New Zealand
Drugs 63:1299-324. 2003..Once-daily boosted saquinavir regimens may be most suitable for HIV-infected patients with busy lifestyles and those who would benefit from directly observed therapy...
Spotlight on verteporfin in subfoveal choroidal neovascularisationSusan J Keam
Adis International Limited, Auckland, New Zealand
Drugs Aging 21:203-9. 2004..Thus, verteporfin therapy provides a valuable option for the management of these patients for whom treatment options are few, and should be considered as a first-line therapy in these difficult-to-manage conditions...
Voriconazole: in the treatment of invasive aspergillosisRichard B R Muijsers
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 62:2655-64; discussion 2665-6. 2002..02 both comparisons) fewer treatment-related adverse events or serious adverse events. The incidence of visual disturbances was significantly (p < 0.001) higher with voriconazole than amphotericin B treatment...
Novolizer: a multidose dry powder inhalerCaroline Fenton
Adis International Limited, Auckland, New Zealand
Drugs 63:2437-45; discussion 2447-8. 2003..Most patients preferred it to previously used MDIs or DPIs. Only 4-5% found the taste feedback unacceptable. Physicians observed improved compliance over 4 weeks in 80% of patients with asthma using Novolizer...
Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary diseaseCaroline Fenton
Adis International Limited, Auckland, New Zealand
Drugs 64:1975-96. 2004..The DPI combining a corticosteroid and long-acting beta2-agonist provides benefits over monotherapy and may encourage patient compliance in COPD...
Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary diseaseGillian M Keating
Wolters Kluwer Health Adis, Auckland, New Zealand
Drugs 67:2383-405. 2007..Thus, salmeterol/fluticasone propionate is an important option in the treatment of patients with COPD who are appropriate candidates for combination therapy with a long-acting bronchodilator and an inhaled corticosteroid...
Intravenous esomeprazoleGillian M Keating
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 64:875-82; discussion 883. 2004..Intravenous esomeprazole was generally well tolerated in patients with erosive oesophagitis, with a tolerability profile similar to that of the oral formulation...
Paricalcitol: a review of its use in the management of secondary hyperparathyroidismDean M Robinson
Adis International Limited, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, Auckland, 1311, New Zealand
Drugs 65:559-76. 2005..Thus, paricalcitol is a useful option for the management of secondary hyperparathyroidism in adults and children with chronic renal failure...
Cinacalcet hydrochlorideJulia A Barman Balfour
Adis International Limited, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, Auckland 1311, New Zealand
Drugs 65:271-81. 2005..Cinacalcet HCl was generally well tolerated in clinical trials. Most treatment-emergent adverse events were mild to moderate in severity...
Intravenous ibandronate: in the treatment of osteoporosisKatherine F Croom
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 66:1593-601; discussion 1602-3. 2006..IV ibandronate was generally well tolerated in clinical trials. Treatment-related adverse events included musculoskeletal events and transient influenza-like symptoms, the latter mainly associated with the first dose...
Cetirizine: a review of its use in allergic disordersMonique P Curran
Adis International Limited, Auckland, New Zealand
Drugs 64:523-61. 2004..On the basis of its favourable efficacy and tolerability profile and rapid onset of action, cetirizine provides an important option for the treatment of a wide range of allergic disorders...
Tramadol/paracetamolKaren McClellan
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 63:1079-86; discussion 1087-8. 2003..5/325 mg provided similar efficacy to that of codeine/paracetamol 30/300 mg in patients with chronic back pain in a 4-week, randomised, double-blind trial (a maximum of 10 tablets or capsules per day of the active drug)...
Entecavir: a review of its use in chronic hepatitis BDean M Robinson
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 66:1605-22; discussion 1623-4. 2006..In addition, the tolerability profile of entecavir was generally similar to that of lamivudine. Thus, entecavir is a primary option in the treatment of chronic HBV infection in both nucleoside-naive and lamivudine-refractory patients...
Oxybutynin extended-release: a review of its use in the management of overactive bladderM Asif A Siddiqui
Adis International Limited, Mairangi Bay, Auckland, New Zealand
Drugs 64:885-912. 2004..Hence, given its overall efficacy/tolerability profile and dosage flexibility, oxybutynin ER provides an excellent treatment option in the first-line pharmacotherapy of OAB...
Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescentsKatherine F Croom
Adis International Limited, Auckland, New Zealand
Drugs 65:2129-35; discussion 2136-7. 2005..Lansoprazole was generally well tolerated in children and adolescents, with the most common treatment-related adverse events being gastrointestinal events and headache...
Esomeprazole: a review of its use in the management of acid-related disorders in the USLesley J Scott
Adis International Limited, 41 Centorian Drive, PB 65901, Mairangi Bay, Auckland 10, New Zealand
Drugs 62:1091-118. 2002..Esomeprazole was also effective in patients with symptomatic GORD. Thus, esomeprazole has emerged as an effective option for first-line therapy in the management of acid-related disorders...
Tacrolimus: a further update of its use in the management of organ transplantationLesley J Scott
Adis International Limited, Auckland, New Zealand
Drugs 63:1247-97. 2003..The optimal immunosuppression regimen is ultimately dependent on balancing such factors as the efficacy of the individual drugs, their tolerability, potential for drug interactions and pharmacoeconomic issues...
Esomeprazole: a review of its use in the management of acid-related disordersLesley J Scott
Adis International Limited, 41 Centorian Drive, PB 65901, Mairangi Bay, Auckland 10, New Zealand
Drugs 62:1503-38. 2002..Esomeprazole also proved beneficial in patients with symptomatic GORD without oesophagitis. Thus, esomeprazole has emerged as an option for first-line therapy in the management of acid-related disorders...
CiclesonideNeil A Reynolds
Adis International Limited, Auckland, New Zealand
Drugs 64:511-9; discussion 520-1. 2004..Inhaled ciclesonide was generally well tolerated in patients with asthma. Ciclesonide did not suppress biochemical markers of adrenal function in 52-week studies. The long-term (>52 weeks) systemic effects of ciclesonide remain unknown...
Verteporfin : a review of its use in the management of subfoveal choroidal neovascularisationSusan J Keam
Adis International Limited, Auckland, New Zealand
Drugs 63:2521-54. 2003..Thus, verteporfin therapy provides a valuable option for the management of these patients for whom treatment options are few, and should be considered as a first-line therapy in these difficult-to-manage conditions...
Donepezil: in vascular dementiaDavid R Goldsmith
Adis International Limited, Auckland, New Zealand
Drugs Aging 20:1127-36. 2003..Donepezil was generally well tolerated in patients with VaD. Most adverse events were mild to moderate in nature, with diarrhoea and nausea being the most common...
Entecavir: a review of its use in chronic hepatitis BLesley J Scott
Wolters Kluwer Health Adis, 41 Centorian Drive, Mairangi Bay, North Shore 0754, Auckland, New Zealand
Drugs 69:1003-33. 2009..Hence, entecavir therapy provides a valuable first-line option in nucleoside-naive patients with chronic HBV infection and is a useful alternative in lamivudine-refractory patients...
Intramuscular paliperidone palmitateSheridan M Hoy
Adis, a Wolters Kluwer Business, Auckland, New Zealand
CNS Drugs 24:227-44. 2010..Intramuscular paliperidone palmitate 39-234 mg was generally well tolerated in adult patients with schizophrenia...
